Invidia Capital Management is a pureplay healthcare investment firm focused on middle-market buyouts in North America. The firm was founded in NY in 2024 by Jo Natauri, formerly the Global Head of Healthcare Private Investing at Goldman Sachs Asset Management. With over 25 years of experience in the healthcare sector, Jo Natauri brings a wealth of expertise in private equity investment, board membership, investment banking, and operational leadership. Invidia aims to reinvent the approach to the middle market by leveraging mega-cap expertise and network, utilizing a wide array of value creation levers, offering broader exit options, and maintaining a balanced risk/reward profile. Within healthcare, the firm targets the following subsectors: supporting research & development (R&D) innovation, tech-enabled services, delivery transformation, and consumer-orientated healthcare.

Articles posted on this Linkedin page by Invidia Capital Management are provided for informational purpose only and are not an offer of investment advisory services or securities.  This information is subject to change and there can be no assurance that Invidia will be able to implement its investment strategy, achieve its investment objectives or avoid substantial losses. Certain statements about the Founder and Invidia made by third-party executives and advisers in these articles are intended to illustrate the founder’s business relationship with such persons rather than Invidia’s capabilities or expertise with respect to investment advisory services.  They were not compensated in connection with providing their statements, although they generally receive compensation from and/or investment opportunities by Invidia.  Such compensation and investments subject participants to potential conflicts of interest in making the statements herein.  



Biotechnology

Health Care

Invidia Capital Management

Org chart

Teams

Offices

Similar companies